UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016097
Receipt number R000018693
Scientific Title Biological tests for major depressive disorder that involve leukocyte gene expression assays.
Date of disclosure of the study information 2015/01/01
Last modified on 2015/01/01 22:49:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Biological tests for major depressive disorder that involve leukocyte gene expression assays.

Acronym

Biological tests for major depressive disorder

Scientific Title

Biological tests for major depressive disorder that involve leukocyte gene expression assays.

Scientific Title:Acronym

Biological tests for major depressive disorder

Region

Japan


Condition

Condition

Major depressive disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The goal of present work was to develop and test the performance of a composite, multi-assay diagnostic test for MDD based on the leukocyte gene expression profiles.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

sensitivity and specificity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Biological tests for major depressive disorder that involve leukocyte gene expression assays.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with major depressive disorder.

Key exclusion criteria

Exclusion criteria for MDDs have not used non-steroidal anti-inflammatory agents, steroids, antipsychotic medications, and anticonvulsants at least past 2 months.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tetsuro Ohmori

Organization

Course of Integrated Brain Sciences, University of Tokushima School of Medicine

Division name

Department of Psychiatry

Zip code


Address

3-18-15 Kuramoto-cho Tokushima-shi

TEL

+81-86-633-7130

Email

ohmori@tokushima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Junichi Iga

Organization

Course of Integrated Brain Sciences, University of Tokushima School of Medicine

Division name

Department of Psychiatry

Zip code


Address

3-18-15 Kuramoto-cho Tokushima-shi

TEL

+81-86-633-7130

Homepage URL


Email

igajunichi@hotmail.com


Sponsor or person

Institute

Course of Integrated Brain Sciences, University of Tokushima School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Health and Labor Science Research Grant from the Japanese Ministry of Health, Labor and welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Tokushima University Hospital


Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2005 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2005 Year 10 Month 01 Day

Last follow-up date

2014 Year 06 Month 30 Day

Date of closure to data entry

2014 Year 06 Month 30 Day

Date trial data considered complete

2014 Year 06 Month 30 Day

Date analysis concluded

2014 Year 07 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 01 Month 01 Day

Last modified on

2015 Year 01 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018693


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name